Results for tag: "Induced Stem Cell"

The Induced Stem Cell (iSC) market is a subset of the larger stem cell market. iSCs are derived from adult cells, such as skin cells, and are reprogrammed to become pluripotent stem cells. These cells can then be used to create a variety of cell types, such as neurons, heart cells, and liver cells. This technology has the potential to revolutionize the field of regenerative medicine, as it allows for the creation of patient-specific cells for use in treatments. iSCs are also being used in drug discovery and development, as they can be used to create models of diseases and test the efficacy of potential treatments. Additionally, iSCs are being used in research to better understand the development of diseases and the underlying mechanisms of cell differentiation. Companies in the iSC market include Cellular Dynamics International, Pluristem Therapeutics, and Fate Therapeutics. These companies are focused on developing iSCs for use in research, drug discovery, and regenerative medicine. Show Less Read more